Evidence map›Paper›PMID 16891509›Full record

ArticleJournal of clinical microbiology2006

Clonal emergence of extended-spectrum beta-lactamase (CTX-M-2)-producing Salmonella enterica serovar Virchow isolates with reduced susceptibilities to ciprofloxacin among poultry and humans in Belgium and France (2000 to 2003).

Sophie Bertrand, François-Xavier Weill, Axel Cloeckaert, Martine Vrints, Eric Mairiaux, Karine Praud, Katlijne Dierick, Christa Wildemauve, Claudine Godard, Patrick Butaye and 3 more

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 148 citations in OpenAlex.

  1. A spotlight on multidrug-resistantFrontiers in microbiology · 2026
    Review
  2. Phylogenetic Analysis and Public Health Implications ofAnimals : an open access journal from MDPI · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Diversity and Resistance Profiles of Human Non-typhoidalAntibiotics (Basel, Switzerland) · 2021
    Article
  10. Corrigendum: First Report of Coexistence ofFrontiers in microbiology · 2021
    Article
  11. First Report of Coexistence ofFrontiers in microbiology · 2021
    Article
  12. Transcriptomic Approach for Understanding the Adaptation ofJournal of microbiology and biotechnology · 2020
    Article
  13. Article
  14. Article
  15. Article
  16. Food-to-Humans Bacterial Transmission.Microbiology spectrum · 2020
    Review
  17. Article
  18. Article
  19. Article
  20. Survey ofJundishapur journal of microbiology · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Sophie BertrandNational Reference Centre for Salmonella and Shigella, Bacteriology Division, Scientific Institute of Public Health, 14 Wytsman Street, B-1050 Brussels, Belgium. sbertrand@iph.fgov.be
François-Xavier Weill
Axel Cloeckaert
Martine Vrints
Eric Mairiaux
Karine Praud
Katlijne Dierick
Christa Wildemauve
Claudine Godard
Patrick Butaye
Hein Imberechts
Patrick A D Grimont
Jean-Marc Collard
Infectiologie Animale et Santé Publique · FRInserm · FRInstitut Pasteur · FRVeterinary and Agrochemical Research Centre · BENational Committee for Quality Assurance · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibiotic treatment is not required in cases of Salmonella enterica gastroenteritis but is essential in cases of enteric fever or invasive salmonellosis or in immunocompromised patients. Although fluoroquinolones and extended-spectrum cephalosporins are the drugs of choice to treat invasive Salmonella, resistance to these antibiotics is increasing worldwide. During the period 2000 to 2003, 90 Salmonella enterica serovar Virchow poultry and poultry product isolates and 11 serovar Virchow human isolates were found to produce an extended-spectrum beta-lactamase, CTX-M-2, concomitantly with a TEM-1 beta-lactamase. The bla(CTX-M-2) gene was located on a large conjugative plasmid (>100 kb). Pulsed-field gel electrophoresis indicated a clonal relationship between the poultry and human isolates. All these isolates displayed additional resistance to trimethoprim-sulfamethoxazole and tetracycline as well as a reduced susceptibility to ciprofloxacin (MICs of between 0.5 and 1 mug/ml). CTX-M-2-producing Salmonella with a reduced susceptibility to fluoroquinolones constitutes a major concern, since such strains could disseminate on a large scale and jeopardize classical antibiotic therapy in immunocompromised patients.

Indexed as

AnimalsAnti-Bacterial AgentsBacterial ProteinsBacterial Typing TechniquesBelgiumbeta-LactamasesChromosomes, BacterialCiprofloxacinCluster AnalysisDNA, BacterialDNA FingerprintingDrug Resistance, Multiple, BacterialElectrophoresis, Gel, Pulsed-FieldFranceGenome, BacterialGenotypeAnti-Bacterial AgentsBacterial Proteinsbeta-lactamase CTX-2beta-LactamasesCiprofloxacinDNA, Bacterial

Identifiers

PMID16891509
PMCPMC1594617
OpenAlexW2145369908

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.